A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 33,406,401 shares of PACB stock, worth $57.5 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
33,406,401
Previous 33,212,454 0.58%
Holding current value
$57.5 Million
Previous $45.5 Million 24.81%
% of portfolio
0.54%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$1.2 - $2.17 $232,736 - $420,864
193,947 Added 0.58%
33,406,401 $56.8 Million
Q2 2024

Jul 26, 2024

SELL
$1.36 - $3.65 $105,648 - $283,542
-77,683 Reduced 0.23%
33,212,454 $45.5 Million
Q1 2024

Apr 18, 2024

SELL
$3.52 - $9.59 $4.27 Million - $11.6 Million
-1,214,136 Reduced 3.52%
33,290,137 $125 Million
Q4 2023

Jan 17, 2024

BUY
$5.97 - $10.36 $28 Million - $48.5 Million
4,681,833 Added 15.7%
34,504,273 $338 Million
Q3 2023

Oct 18, 2023

BUY
$8.23 - $13.93 $26.2 Million - $44.4 Million
3,187,820 Added 11.97%
29,822,440 $249 Million
Q2 2023

Jul 10, 2023

SELL
$9.97 - $14.05 $11.2 Million - $15.7 Million
-1,119,059 Reduced 4.03%
26,634,620 $354 Million
Q1 2023

Apr 17, 2023

BUY
$7.94 - $12.02 $16.4 Million - $24.8 Million
2,061,998 Added 8.03%
27,753,679 $321 Million
Q4 2022

Jan 24, 2023

SELL
$5.67 - $11.2 $17 Million - $33.6 Million
-3,000,813 Reduced 10.46%
25,691,681 $0
Q3 2022

Oct 17, 2022

BUY
$3.93 - $8.57 $2.54 Million - $5.54 Million
646,964 Added 2.31%
28,692,494 $167 Million
Q2 2022

Jul 11, 2022

BUY
$4.02 - $10.43 $3.16 Million - $8.2 Million
786,009 Added 2.88%
28,045,530 $158 Million
Q1 2022

Apr 19, 2022

BUY
$8.43 - $20.9 $7.39 Million - $18.3 Million
876,418 Added 3.32%
27,259,521 $248 Million
Q4 2021

Jan 28, 2022

BUY
$19.26 - $30.08 $70.5 Million - $110 Million
3,660,028 Added 16.11%
26,383,103 $540 Million
Q3 2021

Nov 12, 2021

BUY
$24.86 - $35.02 $55.7 Million - $78.5 Million
2,241,589 Added 10.94%
22,723,075 $581 Million
Q2 2021

Aug 05, 2021

SELL
$22.3 - $36.02 $18.3 Million - $29.5 Million
-819,705 Reduced 3.85%
20,481,486 $716 Million
Q1 2021

May 13, 2021

SELL
$26.38 - $51.15 $190 Million - $368 Million
-7,203,438 Reduced 25.27%
21,301,191 $710 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $90.9 Million - $247 Million
8,659,849 Added 43.64%
28,504,629 $739 Million
Q3 2020

Oct 30, 2020

BUY
$3.61 - $9.87 $41.9 Million - $115 Million
11,613,288 Added 141.08%
19,844,780 $196 Million
Q2 2020

Aug 11, 2020

BUY
$2.65 - $4.03 $10.7 Million - $16.3 Million
4,038,433 Added 96.31%
8,231,492 $28.4 Million
Q1 2020

May 14, 2020

BUY
$2.36 - $5.26 $6.33 Million - $14.1 Million
2,683,645 Added 177.79%
4,193,059 $12.8 Million
Q4 2019

Jan 31, 2020

BUY
$4.6 - $5.57 $3.46 Million - $4.19 Million
752,617 Added 99.45%
1,509,414 $7.76 Million
Q3 2019

Nov 12, 2019

BUY
$4.99 - $6.16 $3.78 Million - $4.66 Million
756,797 New
756,797 $3.91 Million
Q2 2019

Jul 30, 2019

BUY
$5.92 - $7.41 $0 - $0
0 New
0 $0
Q1 2019

May 13, 2019

SELL
$6.8 - $7.4 $4,012 - $4,366
-590 Closed
0 $0
Q4 2018

Feb 01, 2019

SELL
$3.99 - $7.82 $31.1 Million - $60.9 Million
-7,785,895 Reduced 99.99%
590 $4,000
Q3 2018

Nov 07, 2018

BUY
$3.52 - $5.55 $5.16 Million - $8.13 Million
1,465,192 Added 23.18%
7,786,485 $42.1 Million
Q2 2018

Aug 07, 2018

BUY
$2.11 - $3.92 $4.3 Million - $7.98 Million
2,036,596 Added 47.53%
6,321,293 $22.4 Million
Q1 2018

May 14, 2018

BUY
$2.05 - $3.23 $8.35 Million - $13.1 Million
4,070,780 Added 1902.97%
4,284,697 $8.78 Million
Q4 2017

Feb 12, 2018

BUY
$2.59 - $5.44 $464,107 - $974,804
179,192 Added 516.03%
213,917 $565,000
Q3 2017

Nov 09, 2017

BUY
$3.2 - $5.57 $111,120 - $193,418
34,725
34,725 $182,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $387M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.